EYPT:NASDAQ
EyePoint Inc
3,23 $
arrow_downward
-1,22%(-0,040) 1D
3,25 $
arrow_upward
+0,62% (+0,020)bedtimeAfter hours
Closed: 1 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,29 $
High
3,45 $
Low
3,23 $
Mkt. cap
278,47 млн
Avg. vol.
4,15 млн
Volume
2,86 млн
52-wk high
19,01 $
52-wk low
3,23 $
EPS
-3,74 $
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
Open
3,29 $
High
3,45 $
Low
3,23 $
Mkt. cap
278,47 млн
Avg. vol.
4,15 млн
Volume
2,86 млн
52-wk high
19,01 $
52-wk low
3,23 $
EPS
-3,74 $
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
News stories
From web sources and news partners
Simply Wall Street
·
33 минут бұрын
EquipmentShare.com (EQPT) Commits To 1 Gigawatt Of Power Capacity
Yahoo Finance
·
32 минут бұрын
Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026
Investor's Business Daily
·
10 минут бұрын
Twilio To Join S&P 500 Index
Fox Business
·
3 сағат бұрын
October could be a huge month for the stock market. Here's why.
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Массачусетс, Америка Құрама Штаттары
SectorPharmaceutical industry
Websiteeyepoint.bio